ArticleNature medicine2025

Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial.

Jessica S W Borgers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.